DDG-39

CAS No. 119555-47-4

DDG-39( —— )

Catalog No. M35991 CAS No. 119555-47-4

DDG-39 (1-(2,3-dideoxy-2-fluoropentofuranosyl)cytosine) possesses antiviral activity with potent and selective anti-HIV-1 and HBV activity in cell culture. The average antiviral IC50 is 0.61 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 287 Get Quote
5MG 447 Get Quote
10MG 655 Get Quote
25MG 994 Get Quote
50MG 1343 Get Quote
100MG 1764 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    DDG-39
  • Note
    Research use only, not for human use.
  • Brief Description
    DDG-39 (1-(2,3-dideoxy-2-fluoropentofuranosyl)cytosine) possesses antiviral activity with potent and selective anti-HIV-1 and HBV activity in cell culture. The average antiviral IC50 is 0.61 μM.
  • Description
    DDG-39 (1-(2,3-dideoxy-2-fluoropentofuranosyl)cytosine) possesses antiviral activity with potent and selective anti-HIV-1 and HBV activity in cell culture. The average antiviral IC50 is 0.61 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    Antiviral
  • Recptor
    Antiviral | HBV | HIV Protease
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    119555-47-4
  • Formula Weight
    229.21
  • Molecular Formula
    C9H12FN3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    F[C@@H]1[C@@H](O[C@H](CO)C1)N2C(=O)N=C(N)C=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • ITMN4077

    ITMN4077 has antiviral activity against Hepatitis C virus infected in human HuH7 cells assessed as inhibition of HCV subgenomic replicon replication with an EC50 of 2.131μM.

  • Lycorine chloride

    Lycorine chloride is extracted from Lycoris radiata.

  • BTA-188

    BTA-188 is one of the most potent analogues of novel and orally active synthetic benzoxazole and benzothiazole derivatives with significant anti-rhinovirus activity.